NeoGenomics Earnings Watch | Business and Finance News

NeoGenomics is set to drop its Q2 earnings this Tuesday, having just smashed revenue targets last quarter with an 11.1% year-over-year jump to $186.7M — though they’ve missed targets before. Analysts expect a slight slowdown this time, forecasting 8.8% growth, down from last year’s 10.2%. While peers like Quest and Tenet are outperforming with strong beats and stock gains, NeoGenomics is lagging — down 2.5% in the last month despite a $13.89 stock price and a $16.78 target. Investors are watching closely to see if the cancer diagnostics leader can sustain momentum after a history of misses. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/95a89081d4a0d788